Large-scale erythrocyte production method established using erythrocyte progenitor cells

December 5, 2013, Center for iPS Cell Research and Application - Kyoto University

By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice. This technology is expected to contribute to a more reliable transfusion system by offering a new option that allows a stable supply of erythrocytes to be produced without depending on the availability of donor blood. The findings of the research team have been published in the online edition of the Stem Cell Reports.

Erythrocytes, which have the function of transporting oxygen within the body, have no nucleus and are therefore not capable of self-replication. As a result, patients with blood diseases that cause serious anemia are currently dependent on the of blood products prepared from donated blood. Unfortunately, the number of blood donors is on the decline, mainly due to demographic changes in Japan. Hopes for the creation of a more stable transfusion system have centered on the establishment of a technology for large-scale erythrocyte production in vitro, using iPS cells or ES cells. Up to now, however, there have been no reports of erythrocyte production in sufficient quantities for use in transfusion.

Erythrocytes are produced in the body by progressive evolution of into hematopoietic and then erythroblasts. During the differentiation process from hematopoietic progenitor cells, chromosomes in the cell nucleus aggregate and the cell becomes a mature erythrocyte by subsequently losing this nucleus (denucleation). Hematopoietic progenitor cells, however, still have self-replication ability, and if the factors involved in this self-replication could be identified, it might become possible to induce virtually unlimited replication of progenitor cells. The research team had already succeeded in producing megakaryocytes (cells from which platelets develop) with almost unlimited replication ability, but in this latest research, aimed at creating erythrocyte progenitor cells which would have a similar almost unlimited replication ability, they transduced two genes (c-MYC, BCL-XL) into iPS cells and ES cells, which resulted in the production of erythrocyte progenitor cells with virtually unlimited in vitro replication ability.

The research showed that an increase in the expression of the c-MYC gene led to an enhancement of the replication ability of erythrocyte progenitor cells. It was also found that the expression of the BCL-XL gene was higher during the maturation process of erythrocyte progenitor cells than during their replication process. These findings indicate that these genes are important for the maturation of erythrocytes. As the c-MYC gene and BCL-XL gene are present within erythrocyte progenitor cells, methods that make use of them actually mimic the body's own system and can therefore be thought of as safer with a view to future clinical application than the previously developed systems for large-scale erythrocyte production using oncogene-derived from human papillomavirus that are not normally expressed in the human body. According to rough calculations, the amount of culture medium needed to produce enough erythrocytes for a normal transfusion pack (containing one trillion units) is 1,000 - 2,000 liters when using direct differentiation from undifferentiated iPS cells, whereas 50-100 liters is sufficient with our newly developed method. The same results were achieved with cells placed in frozen storage and then thawed. If a more efficient denucleation method can be established along with a method for generating erythrocytes containing only adult-type hemoglobin, progress will have been made toward a more reliable supply of erythrocytes for transfusion in the future.

Explore further: Modeling of congenital amegakaryocytic thrombocytopenia using iPS cell technology

More information: "Immortalization of erythroblast by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cells" Sho-ichi Hirose, Naoya Takayama, Sou Nakamura, Kazumichi Nagasawa, Kiyosumi Ochi, Shinji Hirata, Satoshi Yamazaki, Tomoyuki Yamaguchi, Makoto Otsu, Shinya Sano, Nobuyasu Takahashi, Akira Sawaguchi, Mamoru Ito, Takashi Kato, Hiromitsu Nakauchi, and Koji Eto, Stem Cell Reports, 2013.

Related Stories

Modeling of congenital amegakaryocytic thrombocytopenia using iPS cell technology

August 1, 2013
A research group led by researcher Shinji Hirata and Professor Koji Eto at CiRA has conducted a study in which iPS cells generated from a patient with congenital amegakaryocytic thrombocytopenia (CAMT) were induced to differentiate ...

Study identifies essential molecule in formation of differentiated blood cells

October 7, 2013
New research in the Journal of Experimental Medicine identifies a protein that controls the formation of different types of mature blood cells – a finding that could be important to developing new treatments for blood diseases ...

Research identifies promising tool for cardiac stem cell grafting

December 5, 2013
New research by University of Vermont Associate Professor of Medicine Jeffrey Spees, Ph.D., and colleagues has identified a new tool that could help facilitate future stem cell therapy for the more than 700,000 Americans ...

Discovery of novel regulators of the birth of blood platelets

October 7, 2013
EU research has led to a better understanding of the molecular mechanisms that make certain blood-producing cells function normally. The research will help prevent diseases that lead to heart attacks and strokes.

Researchers identify cells involved in placenta development

November 27, 2013
(Medical Xpress)—Dr. Hanna Mikkola and researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have identified a specific type of cell and a related cell communication pathway that ...

BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy

October 30, 2013
A review article by researchers at Boston University School of Medicine (BUSM) suggests that epigenetics may be a useful target to stop the growth, spread and relapse of cancer. The findings are published online in Volume ...

Recommended for you

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.